• Atherosclerosis, Nature Reviews Disease Primers 

​

•  COMPASS TRIAL  :

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

​

• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. 

​

• ​Major Amputation Rates in Patients with Peripheral Arterial Disease Aged 50 Years and Over in Denmark during the period 1997–2014 and their Relationship with Demographics, Risk Factors, and Vascular Services 

​

• Obesity paradox in peripheral artery disease

​

• Interventions for lower extremity peripheral artery disease 

​

• Peripheral arterial disease in women: The gender

​

• Lower extremity critical limb ischemia: A review of clinical features and management

​

• Artérite à cellules géantes : nouveaux concepts 

​

• Agreement of clinical tests for the diagnosis of peripheral arterial disease

​

• Detection of peripheral arterial disease using Doppler spectrogram based expert system for Point-of-Care applications 

​

• Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in France

​

• Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease

​

• ​Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

​

• A randomized, placebo-controlled trial of canakinumab in patients with peripheral
  artery disease

​

• Chronic kidney disease and risk for cardiovascular and limb outcomes in patientswith symptomatic peripheral artery disease: The EUCLID trial

​

• Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome ​​

​

• The year in cardiology: aorta and peripheral circulation

​

​

         

 

2. MALADIE VEINEUSE THROMBO-EMBOLIQUE

​

​

• Pulmonary embolism, Nature Reviews Disease 

​

• Dernières Recommandations MTEV 2019 

​

• Einstein Trial : Oral Rivaroxaban for Symptomatic Venous Thromboembolism

​

• Amplify Trial : Oral Apixaban for the Treatment of Acute Venous Thromboembolism

​

• Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges  

​

• Extended treatment of cancer-associated thrombosis

​

• Global public awareness of venous thromboembolism

​

• Direct oral anticoagulants for the treatment of venous thromboembolism in
  cancer patients: Potential for drug–drug interactions

​

• Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry

​

• Thrombophilia evaluation in pulmonary embolism

​

• Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability

​

• Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight

​

• Venous Thromboembolism After Major Cancer Surgery

​

• Diagnosis and management of congenital thrombophilia in the era of direct
  oral anticoagulants

​

• ​​Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database

​

• Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism

​

• Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study

​

• Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism)

​

• Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?

​

• Thrombolysis During Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Pulmonary Embolism Increases 30-Day Survival

​

• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

​

• Direct-Acting Oral Anticoagulants in Critically Ill Patients

​

• Long-term Risk of Post-Thrombotic Syndrome after Symptomatic Distal Deep-Vein Thrombosis: The CACTUS-PTS Study

​

• Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope

​

​

​

​

            3.  HYPERTENSION ARTERIELLE

​

• Recommandations mesure de la pression artérielle

​

• HTA essentielle résistante : place de la spironolactone

​

• Dysfonction érectile et traitement antihypertenseur : impact des différentes classes thérapeutiques et conduite à tenir à l'égard du traitement

​

• HTA et traitement hormonal de la menopause

​

​

​

​

                 4 .  THERAPEUTIQUES

​

>  Anticoagulation et Antiagrégation:​

​

• Antiagrégation et anticoagulation en pratique : un ménage délicat

​

• Anticoagulation Strategies in Patients With Cancer
   

• Clot regression effects of rivaroxaban in the treatment of venousthromboembolism in patients with cancer (CRERIT-VTE cancer): study protocol

​

• Net Clinical Benefit of Oral  Anticoagulation Among Older Adults With AF

​

• Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

​

• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

​

• Tinzaparin Sodium Pharmacokinetics in Patients with Chronic KidneyDisease: Practical Implications

​

​

>  Hypocholestérolémiants :​

​

•  Polypills for primary prevention of cardiovascular disease

​

• ​Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat

​

• Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

​

• Myalgies et statines : démêler le vrai du faux

​

• Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

​

• Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins
  on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

​

• Fourier Trial: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

​

• Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

​

• 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

​

• Clinical review on triglycerides

​

​

>  Diabétologie :​

​

• Relationship between metformin and abdominal aortic aneurysm

​

• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

​

• Prise de position de la Société Francophone du Diabète (SFD) : évaluation du rapport
  bénéfices-risques des inhibiteurs de SGLT2

​

​

                 5 . ECHOGRAPHIE-DOPPLER

​

​

• Rôle de l’écho-Doppler pénien sous stimulation pharmacologique de l’érection, dans le diagnostic et le suivi thérapeutique de la dysfonction érectile par fuite caverno-veineuse

​

• Detection of peripheral arterial disease using Doppler spectrogram based expert system for Point-of-Care applications

​

• Velocities of type II endoleaks on Doppler ultrasonography predict outcome

​

• Plantar Acceleration Time: A Novel Technique to Evaluate Arterial Flow to the Foot.

​

• Évaluation et quantification d'une sténose carotidienne par échographie-Doppler

​

​

                   6 .  DIVERS

​

• La cigarette électronique : quels bénéfices, quels risques

​

​

​

​

​

​

​